Skip to main content

12 Result(s)

within Chapter Remove this filter H. Wandt Remove this filter

and

  1. No Access

    Chapter and Conference Paper

    Total Marrow Irradiation (TMI), Busulfan, and Cyclophosphamide for Allografting in Multiple Myeloma. A Pilot Study

    To reduce the incidence of severe graft versus host disease (GvHD) and lower the treatment related mortality(TRM) in allogeneic stem cell transplantation from HLA-identical siblings patients with multiple myel...

    N. Kröger, G. Derigs, H. Wandt… in Transplantation in Hematology and Oncology… (2003)

  2. No Access

    Chapter and Conference Paper

    The 10.000/μl Morning Trigger for Prophylactic Platelet Transfusion is Safe: Prospective Experience in 411 AML Patients

    There is an increasing demand for platelet transfusions and it remains an ongoing challenge for most blood centers to maintain an adequate platelet inventory. Platelet transfusions doubled in the US and in Can...

    H. Wandt, M. Frank, Th. Denzel, W. Aulitzky, H. Bodenstein… in Acute Leukemias VIII (2001)

  3. No Access

    Chapter and Conference Paper

    Long-term Follow Up of a Prospective Multicenter Trial with a High-Dose Cytosine Arabinoside and Daunorubicin Postremission Therapy in Adults with De Novo Acute Myeloid Leukemia

    A total of 149 consecutive de novo acute myeloid leukemia (AML) patients aged 50 years or less (median age = 37 years) were enrolled in this prospective multicenter trial initiated in May 1985. All patients re...

    G. Heil, P. S. Mitrou, D. Hoelzer, M. Freund, H. Link, G. Ehninger… in Acute Leukemias VI (1997)

  4. No Access

    Chapter and Conference Paper

    The 10/NL Trigger for Prophylactic Platelet Transfusion in Acute Myeloid Leukemia: A Prospective Comparative Multicenter Study

    This study shows that the 10/nl trigger for prophylactic platelet transfusion according to the inclusion criteria of our transfusion protocol is as safe as the traditional platelet transfusion threshold of 20/...

    H. Wandt, M. Frank, H. Link, C. Schneider, N. Brack, A. Daoud… in Acute Leukemias VI (1997)

  5. No Access

    Chapter and Conference Paper

    Der Urethraverschlußdruch in Ruhe in Korrelation zum Östrogen- und Progesteron-Rezeptorenstatus im unteren Harntrackt der Frau

    Der Urethraverschlußdruch ist ein wichtiger Parameter für die Kontinenz der Blase. Sie ist nur gewährleistet, wenn unter Streß wie Husten und Nisen ein siffizienter Verschluß des Blasenhalses vorhanden ist. De...

    H. Wolf, H. Wandt, W. Jonat in Gynäkologie und Geburtshilfe 1992 (1993)

  6. No Access

    Chapter and Conference Paper

    Diagnosis of Both c-ALL and Sarcoidosis in the Same Patient

    The simultaneous manifestation of systemic sarcoidosis and a malignant disorder, especially a malignant lymphoma, is a rare phenomen on [1]. While some argue for a common pathogenesis in the simultaneous occur...

    K. Schäfer, H. Wandt, W. M. Gallmeier in Acute Leukemias (1992)

  7. No Access

    Chapter and Conference Paper

    Acute Myeloid Leukemia: An Update of Treatment Results with High-Dose Ara-C Consolidation Therapy

    Substantial progress in chemotherapy and supportive care made it possible in 60%–80% of adult patients suffering from de novo acute myeloid leukemia (AML) to achieve a complete remission (CR) of the disease [1...

    G. Heil, M. Freund, H. Link, P. Mitrou, D. Hoelzer, H. Wandt… in Acute Leukemias (1992)

  8. No Access

    Chapter and Conference Paper

    Östrogen- und Progesteronrezeptoren im Harntrakt der Frau

    Bei der postmenopausalen Frau ist die Therapie der Urge-Inkontinenz durch Gabe von Östrogenen häufig erfolgreich. Auch die Streßinkontinenz soll hiermit positiv beeinflußbar sein. Die Wirkung der Östrogene sol...

    H. Wandt, H. Wolf, W. Jonat in Gynäkologie und Geburtshilfe 1990 (1991)

  9. No Access

    Chapter and Conference Paper

    Mitoxantrone, Cytosine Arabinoside, and VP-16 in 36 Patients with Relapsed and Refractory Acute Myeloid Leukemia

    With intensive induction therapy, complete remission can be achieved in 60%-80% of previously untreated adult patients with acute myeloid leukemia (AML) when a combination of cytarabine arabinoside (Ara-C) and...

    H. Link, M. Freund, H. Diedrich, H. Wilke, J. Austein, M. Henke… in Acute Leukemias II (1990)

  10. No Access

    Chapter and Conference Paper

    Combination of Mitoxantrone and Etoposide in Patients Aged over 60 Years with Untreated Acute Myelogenous Leukemia

    The antileukemic efficacy of mitoxantrone as a single drug or in combination has been reported by several investigators [1–8]. A previous phase II study demonstrated the efficacy of mitoxantrone in combination...

    G. Ehninger, E. Fackler-Schwalbe, M. Freund, G. Heil, M. Henke… in Acute Leukemias II (1990)

  11. No Access

    Chapter and Conference Paper

    Consolidation Therapy with High-Dose Cytosine Arabinoside: Experiences of a Prospective Study in Acute Myeloid Leukemia

    At the present time 60%-80% of adult patients suffering from acute myelogenous leukemia (AML) will achieve complete remission with the available induction chemotherapy including anthracycline antibiotics and c...

    E. Kurrle, G. Ehninger, E. Fackler-Schwalbe, M. Freund, G. Heil… in Acute Leukemias II (1990)

  12. No Access

    Chapter and Conference Paper

    Pain Treatment of Advanced Malignant Diseases by High Cervical Percutaneous Cordotomy

    The authors performed 73 high cervical percutaneous cordotomies on 55 patients, aged from 21 to 74 years. They all suffered from intractable pain caused by malignant tumors. Table 1 demonstrates the painful di...

    W. Bettag, H. Wandt, K. Roosen in Brain Hypoxia (1975)